Retatrutide works as a triple receptor agonist, targeting three key hormonal pathways simultaneously: [1] [4] GLP-1 (glucagon-like peptide-1): Is thought to reduce appetite and slow gastric emptying GIP (glucose-dependent insulinotropic polypeptide): Is thought to enhance insulin secretion and may influence fat metabolism, though human evidence remains limited Glucagon receptor: Has been observed in early studies to increase energy expenditure and promote fat breakdown, though the clinical significance in humans is still being established This triple-action mechanism distinguishes retatrutide from currently approved dual or single agonists
However, caution is advised in patients with end-stage renal disease or severe hepatic impairment due to limited clinical experience
Conclusion: Transform Your Life with Tirzepatide at The Wellness Lab Tirzepatide is a game-changing weight loss solution
doi: 10.1038/srep34563
Here, we determine structures of cagrilintide bound to Gs-coupled, active, amylin receptors (AMY 1 R, AMY 2 R, AMY 3 R) and calcitonin receptor (CTR) and compare cagrilintide interactions and the dynamics of receptor complexes with previously reported structures of receptors bound to rat amylin, salmon calcitonin or recently developed amylin-based peptides
A phase 3, randomized, double-blind CVOT, SURPASS-CVOT, is currently ongoing and aiming to assess tirzepatide vs